Form 4: Emergent BioSolutions Executive Jennifer Fox Reports Stock Transaction
SEC Form 4 Filing
EVP Jennifer Lynne Fox reports disposition of Emergent BioSolutions shares to cover tax obligations.
Summary
- On February 23, 2024, Jennifer Lynne Fox, EVP, Ext Aff, GC, Corp Sec of Emergent BioSolutions Inc., disposed of 229 shares of common stock to cover tax obligations.
- The transaction was executed at a price of $2.74 per share.
- Following the transaction, Fox directly owns 178,564 shares of Emergent BioSolutions Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine transaction to cover tax obligations. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This allows investors to track the buying and selling activity of executives and directors, which can provide insights into their perspectives on the company's performance and future prospects.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it involves a small number of shares disposed of to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of stock transaction (disposal of shares). |
| 02/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.